Rila Therapeutics logo

Rila Therapeutics

Addressing the burden of chronic fibrotic disease

3 employees · est. 2021 · South San Francisco, United...

VS
T-Therapeutics Ltd logo

T-Therapeutics Ltd

Making T-Cell Receptor Biologics a Reality

64 employees · est. 2022 · Cambridge, United Kingdom

Rila Therapeutics is the older company (2021 vs 2022); T-Therapeutics Ltd is the larger of the two.

Side-by-Side Comparison

Rila Therapeutics T-Therapeutics Ltd
Founded
2021 older 2022
Headquarters
South San Francisco, United States Cambridge, United Kingdom
Employees
3 64 larger
Industry
Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Series Unknown Series A
Total Funding
Not tracked yet $48.00M
Funding Rounds
1 1
Services
Not tracked yet Development of T cell receptor-based drugs, Proprietary OpTiMus platform, Cancer treatment research and development
Target Customers
Not tracked yet Cancer patients, Healthcare professionals, Pharmaceutical companies, Investors interested in biotech
Taxonomy
Therapeutics, Fibrotic Diseases, Chronic Diseases, Nephrology, Medical Research, Drug Development, Kidney Disease, Systems Biology, Transgenic Mouse Models, Pathogenesis, Pharmacological Sciences, Medical Innovation, Medical Centers T-Cell Receptor Biologics, TCR Therapeutics, OpTiMus Platform, Humanized TCR Mouse, Antigen-specific TCRs, Mouse Genome Engineering, Biopharmaceutical Drug Development, Single Cell Genomics, Structural Biology, Research And Development, Therapeutic Innovation, University Spin-out, Academic Science Collaboration
Website
rilatx.com t-therapeutics.com
Rila Therapeutics logo

About Rila Therapeutics

Rila Therapeutics is a biotechnology company with the slogan "Addressing the burden of chronic fibrotic disease." Founded in 2021, the company is focused on developing novel therapeutics to treat fibrotic diseases. It was co-founded by John He, the chief of nephrology at Icahn Mount Sinai and a key...

T-Therapeutics Ltd logo

About T-Therapeutics Ltd

T-Therapeutics Ltd, with the slogan "Making T-Cell Receptor Biologics a Reality", is a promising startup in the Biotechnology and Health Care sectors, headquartered in the United Kingdom. Founded in 2022 as a spin-out from the University of Cambridge, it rides on the waves of cutting-edge academic s...

We will tell you when either one moves

BounceWatch watches Rila Therapeutics and T-Therapeutics Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Rila Therapeutics and T-Therapeutics Ltd — by email.

Frequently Asked Questions

Rila Therapeutics — Addressing the burden of chronic fibrotic disease. T-Therapeutics Ltd — Making T-Cell Receptor Biologics a Reality. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Rila Therapeutics has raised undisclosed funding while T-Therapeutics Ltd has raised $48.00M.
Rila Therapeutics and T-Therapeutics Ltd operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Rila Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Rila Therapeutics on 12 Sep 2024, and T-Therapeutics Ltd on 25 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes